Compromise of Second-Line Antiretroviral Therapy Due to High Rates of Human Immunodeficiency Virus Drug Resistance in Mozambican Treatment-Experienced Children With Virologic Failure | Zendy

Paula Vaz | Zendy; W Chris Buck | Zendy; Nilesh Bhatt | Zendy; Dulce Bila | Zendy; Andrew F. Auld | Zendy; James Houston | Zendy; Loide Cossa | Zendy; Charity Alfredo | Zendy; Kebba Jobarteh | Zendy; Jennifer Sabatier | Zendy; Eugénia Macassa | Zendy; Amina de Sousa | Zendy; Josh DeVos | Zendy; Ilesh Jani | Zendy; Chunfu Yang | Zendy

Open Access

Compromise of Second-Line Antiretroviral Therapy Due to High Rates of Human Immunodeficiency Virus Drug Resistance in Mozambican Treatment-Experienced Children With Virologic Failure

Author(s) -

Paula Vaz,

W Chris Buck,

Nilesh Bhatt,

Dulce Bila,

Andrew F. Auld,

James Houston,

Loide Cossa,

Charity Alfredo,

Kebba Jobarteh,

Jennifer Sabatier,

Eugénia Macassa,

Amina de Sousa,

Josh DeVos,

Ilesh Jani,

Chunfu Yang

Publication year - 2018

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/piy102

Subject(s) - medicine , nevirapine , regimen , stavudine , lamivudine , viral load , immunosuppression , resistance mutation , pediatrics , drug resistance , immunology , antiretroviral therapy , human immunodeficiency virus (hiv) , virus , hepatitis b virus , reverse transcriptase , rna , biochemistry , chemistry , biology , microbiology and biotechnology , gene

Virologic failure (VF) is highly prevalent in sub-Saharan African children on antiretroviral therapy (ART) and is often associated with human immunodeficiency virus drug resistance (DR). Most children still lack access to routine viral load (VL) monitoring for early identification of treatment failure, with implications for the efficacy of second-line ART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research